An interventional study of Nexel Total Elbow in Elbow Joint Destruction, Post-traumatic Lesions and Ankylosed Joints, sponsored by Zimmer Biomet. Recruiting at 11 sites in 8 countries. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-07-09.
Sponsored by Zimmer Biomet · Not applicable, Interventional, and Treatment
The objectives of the study are to confirm safety and performance of the Zimmer Nexel Total Elbow when used in primary or revision total elbow replacement.
The objectives of the study are to confirm safety and performance of the Zimmer® Nexel™ Total Elbow when used in primary or revision total elbow replacement by analysis of standard scoring systems, radiographs, and adverse event records.
The safety of the device will be monitored using the frequency and incidence of reporting adverse events.
The performance of the device will be evaluated by assessing the pain and functional performance, survival of the device, patient health status, and radiographic success of the implant.
Patient is a candidate for primary or revision total elbow arthroplasty, based on symptoms including at least one of the following:
Additional Retrospective Arm Inclusion Criteria
Exclusion Criteria:
Patients who have had primary or revision total elbow arthroplasty using the Nexel Total Elbow, and who have surgical details available
Device: Nexel Total Elbow
Patients who are having primary or revision total elbow arthroplasty who will receive the Nexel Total Elbow
Device: Nexel Total Elbow
Nexel Total Elbow used in primary or revision total elbow arthroplasty
Also known as: Nexel Elbow, Nexel
Survivorship
Based on removal or intended removal of the device and determined using the Kaplan-Meier method
Time frame: 10 years
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Zimmer Biomet